Cargando…

5-HT(3) Receptor Antagonism: A Potential Therapeutic Approach for the Treatment of Depression and other Disorders

BACKGROUND: Depression or Major depressive disorder (MDD) is a prolonged condition of sadness. MDD is the most common mental disorder that affects more than 264 million people worldwide. According to the monoamine hypothesis, serotonin (5-hydroxy tryptamine, 5-HT), dopamine (DA) and norepinephrine (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhatt, Shvetank, Devadoss, Thangaraj, Manjula, Santhepete Nanjundaiah, Rajangam, Jayaraman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762176/ https://www.ncbi.nlm.nih.gov/pubmed/33059577 http://dx.doi.org/10.2174/1570159X18666201015155816

Ejemplares similares

Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): An approach using rodent behavioral antidepressant tests
por: Bhatt, Shvetank, et al.
Publicado: (2013)

Antidepressant-like activity of (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a), a novel 5-HT(3) receptor antagonist: An investigation in behaviour-based rodent models of depression
por: Mahesh, Radhakrishnan, et al.
Publicado: (2012)

Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice
por: Bhatt, Shvetank, et al.
Publicado: (2014)

Anxiolytic-like effect of (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl)methanone (6g) in experimental mouse models of anxiety
por: Bhatt, Shvetank, et al.
Publicado: (2013)

Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats
por: Gupta, Deepali, et al.
Publicado: (2013)

Ameliorative Efficacy of the Cassia auriculata Root Against High-Fat-Diet + STZ-Induced Type-2 Diabetes in C57BL/6 Mice
por: Salma, Babu, et al.
Publicado: (2020)

Pharmacological evaluation of novel 5-HT(3) receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery
por: Gupta, Deepali, et al.
Publicado: (2015)

Antidepressant-like effect of a novel 5-HT(3) receptor antagonist N-(benzo[d] thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide 6k using rodents behavioral battery tests
por: Kurhe, Yeshwant, et al.
Publicado: (2014)

Anti-anxiety effect of a novel 5-HT(3) receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice
por: Kurhe, Yeshwant Vijay, et al.
Publicado: (2014)

Antidepressant Potential of 5-HT(3) Receptor Antagonist, N-n- propyl-3-ethoxyquinoxaline-2-carboxamide (6n)
por: Mahesh, R, et al.
Publicado: (2012)

Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy
por: Okubo, Ruri, et al.
Publicado: (2021)

The role of 5-HT receptors in depression
por: Yohn, Christine N., et al.
Publicado: (2017)

Discovery of Nonracemic Amisulpride to Maximize Benefit/Risk of 5‐HT7 and D2 Receptor Antagonism for the Treatment of Mood Disorders
por: Hopkins, Seth C., et al.
Publicado: (2021)

5-HT(7) receptor signaling: improved therapeutic strategy in gut disorders
por: Kim, Janice J., et al.
Publicado: (2014)

Neurokinin 1 receptor antagonism promotes active stress coping via enhanced septal 5-HT transmission
por: Singewald, Georg M, et al.
Publicado: (2007)

Combined Antagonism of 5-HT(2) and NMDA Receptors Reduces the Aggression of Monoamine Oxidase a Knockout Mice
por: Frau, Roberto, et al.
Publicado: (2022)

5‐HT(2) receptor antagonism reduces human motoneuron output to antidromic activation but not to stimulation of corticospinal axons
por: Thorstensen, Jacob R., et al.
Publicado: (2022)

The therapeutic promise of ATP antagonism at P2X3 receptors in respiratory and urological disorders
por: Ford, Anthony P., et al.
Publicado: (2013)

Overcoming Depression with 5-HT(2A) Receptor Ligands
por: Zięba, Agata, et al.
Publicado: (2021)

Antagonism of Therapeutic Agents
Publicado: (1878)

Changes of Serotonin (5-HT), 5-HT2A Receptor, and 5-HT Transporter in the Sprague-Dawley Rats of Depression, Myocardial Infarction and Myocardial Infarction Co-exist with Depression
por: Liu, Mei-Yan, et al.
Publicado: (2015)

Therapeutic Potential of 5-HT(2C) Receptor Ligands
por: Jensen, Nanna H., et al.
Publicado: (2010)

Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
por: Peckham, Alyssa M., et al.
Publicado: (2018)

Translating the promise of 5HT(4) receptor agonists for the treatment of depression
por: Murphy, Susannah E, et al.
Publicado: (2021)

5-HT(3) Receptors: A Potential Therapeutic Target for Epilepsy
por: Zhao, Hongyan, et al.
Publicado: (2018)

Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor
por: Lee, Jieon, et al.
Publicado: (2021)

Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects
por: Peng, Liang, et al.
Publicado: (2014)

Receptor–Receptor Interactions in Multiple 5-HT1A Heteroreceptor Complexes in Raphe-Hippocampal 5-HT Transmission and Their Relevance for Depression and Its Treatment
por: Borroto-Escuela, Dasiel O., et al.
Publicado: (2018)

Dissociable Effects of 5-HT2C Receptor Antagonism and Genetic Inactivation on Perseverance and Learned Non-Reward in an Egocentric Spatial Reversal Task
por: Nilsson, Simon R. O., et al.
Publicado: (2013)

5-HT(4) Receptors Are Not Involved in the Effects of Fluoxetine in the Corticosterone Model of Depression
por: Amigo, Josep, et al.
Publicado: (2021)

Single Administration of HBK-15—a Triple 5-HT(1A), 5-HT(7), and 5-HT(3) Receptor Antagonist—Reverses Depressive-Like Behaviors in Mouse Model of Depression Induced by Corticosterone
por: Pytka, Karolina, et al.
Publicado: (2017)

GRP Receptor Regulates Depression Behavior via Interaction With 5-HT2a Receptor
por: Xiang, Dan, et al.
Publicado: (2020)

Editorial: Depression, Burnout, and Other Mood Disorders: Interdisciplinary Approaches
por: Laurent, Éric, et al.
Publicado: (2017)

Chronic Administration of 5-HT1A Receptor Agonist Relieves Depression and Depression-Induced Hypoalgesia
por: Jiang, Zhao-Cai, et al.
Publicado: (2014)

Alterations of Expression of the Serotonin 5-HT4 Receptor in Brain Disorders
por: Rebholz, Heike, et al.
Publicado: (2018)

Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief
por: Hegron, Alan, et al.
Publicado: (2023)

The Antagonism of Therapeutic Agents: And What It Teaches
Publicado: (1879)

Physiological Antagonism the Therapeutic Law of Cure
por: Ward, Electus B.
Publicado: (1879)

Agonism and Antagonism at the Insulin Receptor
por: Knudsen, Louise, et al.
Publicado: (2012)

5-HT(3) Receptors
por: Lummis, Sarah C. R.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6uj5eoog1tv3c1gtrtfmsf04hf